Huang, Zhi-qiang <br/><br/>
Differential responses by pancreatic carcinoma cell lines to prolonged exposure to Erbitux (IMC-C225) anti-EGFR antibody.  [electronic resource] 

 -  The Journal of surgical research  May 2003 
 - 274-83 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0022-4804 
<br/><br/><label>Standard No.: </label>10.1016/s0022-4804(03)00076-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adaptor Proteins, Signal Transducing<br/>Adenocarcinoma--chemistry<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized<br/>Apoptosis<br/>Cell Division--drug effects<br/>Cetuximab<br/>Cobalt Radioisotopes<br/>Deoxycytidine--analogs & derivatives<br/>Electrophoresis, Polyacrylamide Gel<br/>Epidermal Growth Factor--metabolism<br/>ErbB Receptors--analysis<br/>Flow Cytometry<br/>GRB2 Adaptor Protein<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Immunosorbent Techniques<br/>Iodine Radioisotopes<br/>Mitogen-Activated Protein Kinases--metabolism<br/>Pancreatic Neoplasms--chemistry<br/>Proteins--metabolism<br/>Proto-Oncogene Proteins--analysis<br/>Proto-Oncogene Proteins c-bcl-2--analysis<br/>Tumor Cells, Cultured<br/>bcl-2-Associated X Protein<br/>bcl-X Protein<br/>Gemcitabine